The Current Ratio as of September 2024 (TTM) for ORIC Pharmaceuticals, Inc. (ORIC) is 15.08

According to ORIC Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 15.08. This represents a change of 2.16% compared to the average of 14.76 of the last 4 quarters.

ORIC Pharmaceuticals, Inc. (ORIC) Historical Current Ratio (quarterly & annually)

How has ORIC Current Ratio performed in the past?

The mean historical Current Ratio of ORIC Pharmaceuticals, Inc. over the last ten years is 16.68. The current 15.08 Current Ratio has changed 8.94% with respect to the historical average. Over the past ten years (40 quarters), ORIC's Current Ratio was at its highest in in the March 2021 quarter at 36.49. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

ORIC Pharmaceuticals, Inc. (ORIC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ORIC Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ORIC Pharmaceuticals, Inc. (ORIC) Average Current Ratio

How has ORIC Current Ratio performed in the past?

The current Current Ratio of ORIC Pharmaceuticals, Inc. (ORIC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ORIC Pharmaceuticals, Inc. (ORIC) Current Ratio vs. Peers

How is ORIC’s Current Ratio compared to its peers?

ORIC Pharmaceuticals, Inc.’s Current Ratio is less than Seer, Inc. (17.59), greater than Anebulo Pharmaceuticals, Inc. (5.32), less than Cullinan Oncology, Inc. (28.87), greater than C4 Therapeutics, Inc. (5.09), less than Molecular Partners AG (0), greater than Mineralys Therapeutics, Inc. (14.58), greater than AN2 Therapeutics, Inc. (11.20), greater than Pharvaris N.V. (10.61), less than PepGen Inc. (18.45), greater than Werewolf Therapeutics, Inc. (7.45), greater than Edgewise Therapeutics, Inc. (12.13), less than Decibel Therapeutics, Inc. (30.24), greater than Celcuity Inc. (3.03), greater than Theseus Pharmaceuticals, Inc. (14.95), less than PMV Pharmaceuticals, Inc. (29.93), less than Enliven Therapeutics, Inc. (19.22), greater than Immuneering Corporation (14.39), greater than null (9.39),

Build a custom stock screener for ORIC Pharmaceuticals, Inc. (ORIC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ORIC Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ORIC Pharmaceuticals, Inc. (ORIC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ORIC Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.